EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

In The News

India’s First Zika Vaccine Clears CDSCO Panel for Phase I Trials - India’s first Zika virus vaccine has moved a significant step closer to human testing. The Subject Expert Committee (SEC) on vaccines at the Central Drugs Standard Control Organisation (CDSCO) has recommended that Human Biologicals Institute (HBI), the human health division of Indian Immunologicals Limited (IIL), be permitted to conduct Phase I clinical trials in healthy […]
India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield - India has approved its first midazolam nasal spray. CDSCO granted New Drug Permission to Biodeal Pharmaceuticals for an indigenously developed Midazolam Nasal Spray 1.25% w/v on 5 May 2025 — the first approval of this product and this strength in the country. On top of that, NPPA’s Multidisciplinary Committee of Experts has recommended a five-year […]
NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027 - India’s medical-device price cap on orthopaedic knee implants will stay in force past its scheduled expiry. The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has extended the validity of ceiling prices for orthopaedic knee implants used in knee replacement systems until January 15, 2027, according to an official statement issued on November […]
India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals - India regulates plant-based medicines through three legally separate doors, and only one of them is treated like a modern drug. That door is the phytopharmaceutical category — a purified, standardised plant fraction that must be characterised by at least four bioactive markers before CDSCO will look at it as a therapeutic. A review published in […]

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Stay Connected

If you have any question,please connect us.

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities